Abstract

Six thyroid analytes (free and total triiodothyronine and thyroxine, thyrotropin and thyroglobulin) have been followed up over a 10 year period in a national external quality assessment scheme (EQAS) organised by the Institute for Standardisation and Documentation in the Medical Laboratory (INSTAND).

1. The following points were observed:


2. The introduction of samples with properties similar to patient serum (filtered, recalcified defibrinated plasma without stripping) improved performance and inter-method comparability for the free thyroid hormones.


3. In general, the performance in EQAS has improved over the past decade, an exception being thyroglobulin, where precision has improved at the expense of inter-method comparability.


4. Regular statistical analysis of EQAS data allows adjustment of target ranges to be made when necessary.


5. Analytes which are not dependent on binding proteins – thyrotropin and the total thyroid hormones – give rise to similar performance when stripped and spiked plasma or recalcified non-stripped and spiked plasma is used as sample.


6. Whereas certain analytes have had a relatively constant number of participants over the past decade (total thyroid hormones), others have shown a drastic increase (free thyroxine from 67 to 620; thyrotropin from 295 to 724) reflecting the medical demand for the analytes.